Free Trial
NASDAQ:DYNT

Dynatronics (DYNT) Stock Price, News & Analysis

$0.16
+0.01 (+5.19%)
(As of 09/6/2024 08:50 PM ET)
Today's Range
$0.15
$0.16
50-Day Range
$0.15
$0.28
52-Week Range
$0.15
$0.91
Volume
4,300 shs
Average Volume
288,788 shs
Market Capitalization
$849,280.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.80
DYNT stock logo

About Dynatronics Stock (NASDAQ:DYNT)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

DYNT Stock Price History

DYNT Stock News Headlines

Dynatronics (NASDAQ:DYNT) Now Covered by Analysts at StockNews.com
Fmr CIA Advisor reveals PEACEMAKER superweapon
Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.
Dynatronics Corporation (DYNT)
Dynatronics Corp DYNT
Fmr CIA Advisor reveals PEACEMAKER superweapon
Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.
Why Is Dynatronics (DYNT) Stock Up 93% Today?
Dynatronics Corp.
What Wall Street expects from Silk Road Medical's earnings
See More Headlines
Receive DYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dynatronics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/28/2023
Today
9/09/2024
Next Earnings (Estimated)
9/26/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DYNT
Employees
200
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$3.80
High Stock Price Target
$3.80
Low Stock Price Target
$3.80
Potential Upside/Downside
+2,275.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-4,970,000.00
Pretax Margin
-13.08%

Debt

Sales & Book Value

Annual Sales
$33.60 million
Book Value
$2.19 per share

Miscellaneous

Free Float
4,825,000
Market Cap
$849,280.00
Optionable
Not Optionable
Beta
0.20

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Brian D. Baker (Age 57)
    CEO, President & Director
    Comp: $273k
  • Mr. Gabe Ellwein
    Chief Financial Officer

DYNT Stock Analysis - Frequently Asked Questions

How have DYNT shares performed this year?

Dynatronics' stock was trading at $0.5850 at the start of the year. Since then, DYNT stock has decreased by 72.6% and is now trading at $0.16.
View the best growth stocks for 2024 here
.

How were Dynatronics' earnings last quarter?

Dynatronics Co. (NASDAQ:DYNT) posted its earnings results on Thursday, September, 28th. The medical equipment provider reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by $0.29. The medical equipment provider had revenue of $8.44 million for the quarter, compared to analysts' expectations of $8.04 million. Dynatronics had a negative net margin of 13.07% and a negative trailing twelve-month return on equity of 55.14%.

When did Dynatronics' stock split?

Dynatronics's stock reverse split before market open on Tuesday, January 31st 2023. The 1-5 reverse split was announced on Tuesday, January 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

How do I buy shares of Dynatronics?

Shares of DYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Dynatronics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dynatronics investors own include Biocept (BIOC), Nuwellis (CHFS), Heat Biologics (HTBX), Bionano Genomics (BNGO), iBio (IBIO), Alto Ingredients (PEIX) and Sorrento Therapeutics (SRNE).

This page (NASDAQ:DYNT) was last updated on 9/9/2024 by MarketBeat.com Staff

From Our Partners